Miranda has devoted over 30 years of research to better understanding the process of damage and repair of normal skeletal muscle. This extends into trying to more precisely define the early events downstream of the dystrophin deficiency that are responsible for the pathology of DMD. She has a long standing interest in cell therapy to replace the defective gene and more recently in pharmaceutical approaches to reduce the severity of the disease.
Her research has a strong engagement with DMD Parent Groups (in the USA, Europe, UK, Brazil). She recently initiated an Indian Ocean Rim Muscle Colloquium (2009) to facilitate networks in this region. For more information please see http://school.anhb.uwa.edu.au/personalpages/grounds/